Suggestions
Gloria Seibert
Founder & CEO at Temedica | Entrepreneur & Angel Investor | Member Of The Supervisory Board @WAREMA | Global Innovator at World Economic Forum
Gloria Seibert is the founder and CEO of Temedica, a Germany-based health insights company, driven by the vision of personalized healthcare for individuals.
She recognized the disparity in treatments for patients sharing a diagnosis but leading vastly different lives, prompting her to launch Temedica in 2016 with a focus on revolutionizing healthcare and promoting personalized medicine.
Under her leadership, Temedica has become a prominent player in the European health sector, offering Real World Evidence ecosystems and the Permea product suite to provide actionable health insights for various healthcare stakeholders.
Gloria's educational background includes a Bachelor of Science in General Management/Business Law from EBS Universität für Wirtschaft und Recht, studies in Economics and Business Innovations at The University of Hong Kong, and Computer Software Engineering at Dev Bootcamp.
She has held various key positions in organizations such as Industry Advisor at Armira, Global Innovator at World Economic Forum, Member Of the Supervisory Board at WAREMA Renkhoff SE, Founder & CEO at Temedica, Junior Engagement Manager at McKinsey & Company, Summer Analyst - Investment Banking/M&A at Goldman Sachs, and Intern - Valuation & Strategy at PricewaterhouseCoopers.
Highlights
📊 𝗪𝗲 𝗣𝘂𝘁 𝗡𝘂𝗺𝗯𝗲𝗿𝘀 𝗕𝗲𝗵𝗶𝗻𝗱 𝗟𝗼𝗻𝗴-𝗦𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝘀𝘀𝘂𝗺𝗽𝘁𝗶𝗼𝗻𝘀
People living with chronic illnesses face greater challenges in managing their daily lives. But where exactly are these challenges most significant? And where does it make sense to offer targeted help and support?
A good example is the often overlooked impact of chronic skin diseases, such as the chronic inflammatory skin condition 𝗛𝗶𝗱𝗿𝗮𝗱𝗲𝗻𝗶𝘁𝗶𝘀 𝗦𝘂𝗽𝗽𝘂𝗿𝗮𝘁𝗶𝘃𝗮 (𝗛𝗦), on work capacity and quality of life.
In one of our studies, we revealed that patients with moderate to severe cases of HS report a 43.3% reduction in their ability to work
Through comprehensive patient surveys, we've uncovered just how deeply these conditions affect daily functioning and well-being. Patients struggle not only with visible symptoms but also with the hidden emotional and psychological toll.
Understanding these impacts is crucial for HCPs, policymakers, and employers: By recognizing the full extent of these conditions' effects, interdisciplinary approaches can develop better support systems and treatment plans that help patients to continue to participate and contribute to society.
#unveilingtheassumptions #patientjourney #realworldevidence
